Brown-Forman Corporation
BF-B
$29.49
-2.71%
Brown-Forman Corporation is a leading producer and marketer of premium alcoholic beverages, operating in the Beverages - Wineries & Distilleries industry with a portfolio anchored by the iconic Jack Daniel's Tennessee Whiskey brand, along with other spirits, wines, and ready-to-drink products. The company is a well-established market leader in the American whiskey category, leveraging a strong brand heritage and a global distribution network to maintain its competitive position. The current investor narrative is focused on the company's ability to navigate a challenging macroeconomic environment, as evidenced by recent analyst rating adjustments, while also driving growth through its premium portfolio and the expansion of its ready-to-drink offerings.…
BF-B
Brown-Forman Corporation
$29.49
Investment Opinion: Should I buy BF-B Today?
Rating & Thesis: The stock is a HOLD. The core thesis is that Brown-Forman is a high-quality, financially sound company caught in a growth rut, making its current valuation a fair compromise between its defensive strengths and its lack of a growth catalyst.
Supporting Evidence: The Hold rating is supported by four key data points. First, the valuation is in a middle ground: the forward P/E of 17.35x is a discount to its own history but a premium to slower-growing staples, making it neither clearly cheap nor expensive. Second, revenue growth is anemic at 2.71% YoY, insufficient to drive a re-rating. Third, profitability remains stellar with a 60.87% gross margin and strong free cash flow generation of $730M TTM, providing a floor. Fourth, analyst sentiment is neutral, reflecting a consensus that the stock is fairly valued at these levels absent a growth reacceleration.
Risks & Conditions: The two biggest risks to the thesis are 1) prolonged sub-3% revenue growth leading to further multiple compression, and 2) a failure of the Ready-to-Drink segment to gain meaningful scale. This Hold would upgrade to a Buy if the forward P/E compressed below 15x or if quarterly revenue growth sustainably accelerated above 5%. It would downgrade to a Sell if revenue growth turned negative or if operating margins showed sustained contraction. The valuation verdict is that the stock is fairly valued relative to its current growth profile and financial strength.
Sign up to view all
BF-B 12-Month Price Forecast
The outlook for BF-B over the next 12 months is one of range-bound consolidation with a neutral bias. The company's impeccable financial health (D/E 0.68, FCF $730M) provides a solid floor, but the lack of a visible growth catalyst caps the upside. The most probable path is a base case where the stock oscillates between the high-$20s and low-$30s as investors await clearer signs of top-line momentum. The stance would upgrade to bullish on confirmation of sustained revenue growth above 5% or a valuation drop below a 15x P/E. It would turn bearish if the technical rebound fails and the stock breaks below $22.61, signaling a resumption of the downtrend.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Brown-Forman Corporation's 12-month outlook, with a consensus price target around $38.34 and implied upside of +30.0% versus the current price.
Average Target
$38.34
16 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
16
covering this stock
Price Range
$24 - $38
Analyst target range
The stock is covered by 16 analysts, indicating substantial institutional interest. The consensus sentiment appears neutral, as evidenced by several recent rating actions from firms like Citigroup and JP Morgan moving to 'Neutral' from more bearish stances, though Barclays maintains an 'Overweight' rating. While a specific average target price is not provided in the data, the recent price action and rating adjustments suggest analysts are cautiously reassessing the stock after its significant decline. The target price range implied by analyst actions is wide, reflecting high uncertainty; the high-end targets likely assume a successful execution of the premiumization strategy and margin recovery, while the low-end targets price in continued macroeconomic headwinds, competitive pressures, and potential market share loss. The pattern of recent ratings shows a shift from outright bearishness (Sell/Underweight) to a more neutral stance, which could be an early signal that the downside risk is perceived to be limited at current levels.
Bulls vs Bears: BF-B Investment Factors
The evidence presents a classic battle between value and growth concerns. The bull case is anchored in strong financials, a discounted valuation relative to history, and signs of a technical bottom. The bear case is driven by persistent underperformance, weak revenue growth, and high short interest. Currently, the bearish evidence holds more weight, as the fundamental growth deceleration is the primary driver of the stock's poor performance. The single most important tension in the investment debate is whether the company's robust profitability and iconic brands can overcome its anemic top-line growth. If revenue growth re-accelerates to mid-single digits, the valuation discount and strong cash flow will likely propel the stock higher. If growth remains stagnant, the premium multiple will continue to compress despite the strong balance sheet.
Bullish
- Strong Financial Health & Cash Flow: The company maintains a robust balance sheet with a low debt-to-equity ratio of 0.68 and a high current ratio of 3.88, indicating ample liquidity. This is supported by strong trailing twelve-month free cash flow of $730 million, providing significant flexibility for dividends, buybacks, and growth investments without financial strain.
- Attractive Valuation vs. Own History: The stock's trailing P/E of 18.95x is near the lower end of its recent historical range, a significant discount to the multiples above 30x seen in 2021-2022. This suggests the stock is trading at a discount to its own historical valuation, potentially pricing in overly pessimistic growth expectations.
- Robust Profitability & Defensive Margins: The company exhibits strong and stable profitability, with a gross margin of 60.87% and a net margin of 21.86% in the latest quarter. This high-margin, cash-generative profile is characteristic of a premium brand owner and provides resilience in challenging economic environments.
- Significant Recent Momentum & Technical Rebound: The stock has surged 21.76% over the past month and 14.65% over three months, a sharp divergence from its longer-term downtrend. Trading at $29.49, it is closer to its 52-week low of $22.61 than its high of $36.18, suggesting a potential bottoming process and deep value zone.
Bearish
- Persistent Long-Term Underperformance: The stock has significantly underperformed the market, with a 1-year price change of -9.40% versus the S&P 500's gain of 29.52%. This underperformance, coupled with a massive 52.26% maximum drawdown, indicates deep-seated investor concerns that have not been resolved.
- Anemic Revenue Growth Trajectory: Top-line growth is tepid, with the most recent quarterly revenue of $1.063 billion representing only a 2.71% year-over-year increase. This low-single-digit growth profile challenges the premium valuation typically afforded to growth-oriented consumer staples.
- High Short Interest & Skepticism: A short ratio of 11.39 indicates a substantial level of bearish bets against the stock. This high short interest reflects persistent market skepticism regarding the company's ability to reignite growth and justifies the stock's volatile, downtrending price action over the past year.
- Premium Valuation vs. Sector Peers: Despite its recent decline, the stock's forward P/E of 17.35x and P/S ratio of 4.14x still command a premium compared to many traditional consumer staples. This leaves it vulnerable to further valuation compression if growth does not accelerate to justify the multiple.
BF-B Technical Analysis
The stock is in a pronounced downtrend over the past year, evidenced by a 1-year price change of -9.40%, significantly underperforming the S&P 500, which gained 29.52% over the same period. With a current price of $29.49, the stock is trading at approximately 36% of its 52-week range ($22.61 to $36.18), positioning it much closer to its 52-week low and suggesting it is in a deep value zone, though it also indicates persistent selling pressure and a lack of positive momentum. Recent momentum shows a sharp but volatile recovery attempt, with the stock up 21.76% over the past month and 14.65% over the past three months, a significant divergence from the longer-term downtrend that could signal a potential bottoming process or a short-term relief rally. The stock's beta of 0.421 indicates it is significantly less volatile than the broader market, which is typical for a consumer defensive name, but this low beta has not shielded it from a substantial 52.26% maximum drawdown, highlighting the severity of its decline. Key technical levels are clearly defined, with immediate resistance at the recent high near $30.31 and major resistance at the 52-week high of $36.18, while support is firmly established at the 52-week low of $22.61; a sustained breakout above the $30-$31 area would be needed to signal a more credible trend reversal, while a breakdown below $22.61 would open the door to new lows.
Beta
0.42
0.42x market volatility
Max Drawdown
-52.3%
Largest decline past year
52-Week Range
$23-$36
Price range past year
Annual Return
-9.4%
Cumulative gain past year
| Period | BF-B Return | S&P 500 |
|---|---|---|
| 1m | +21.8% | +2.6% |
| 3m | +14.6% | -2.3% |
| 6m | +12.3% | +2.6% |
| 1y | -9.4% | +27.3% |
| ytd | +13.9% | -0.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BF-B Fundamental Analysis
Revenue growth has been modest but positive, with the most recent quarterly revenue of $1.063 billion representing a 2.71% year-over-year increase, continuing a trend of low-single-digit growth seen in recent quarters. The company's Whiskey segment, generating $797 million in the latest period, is the dominant growth driver, while the smaller Ready-to-Drink segment at $146 million represents a faster-growing category. Profitability remains robust with a net income of $267 million for the quarter and a healthy gross margin of 60.87%, though operating margins have shown some quarterly fluctuation, with the latest operating income ratio at 32.27% compared to 31.14% in the year-ago quarter, indicating stable but not expanding core profitability. The company's balance sheet and cash flow generation are strong, with a debt-to-equity ratio of 0.68 indicating a conservative capital structure, a current ratio of 3.88 signaling ample liquidity, and trailing twelve-month free cash flow of $730 million providing significant financial flexibility to fund dividends, share repurchases, and organic growth without reliance on excessive external financing.
Quarterly Revenue
$1.1B
2026-01
Revenue YoY Growth
+0.02%
YoY Comparison
Gross Margin
+0.60%
Latest Quarter
Free Cash Flow
$730000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BF-B Overvalued?
Given the company's consistent profitability with a net income of $267 million, the primary valuation metric is the P/E ratio. The trailing P/E ratio stands at 18.95x, while the forward P/E is slightly lower at 17.35x, indicating the market expects modest earnings growth in the near term. Compared to its own historical range, the current trailing P/E of 18.95x is below the multi-year highs seen above 30x in 2021-2022 and is near the lower end of its recent historical band, suggesting the stock is trading at a discount to its own historical valuation, which may reflect lowered growth expectations or a sector-wide de-rating. The stock trades at a premium to typical consumer staples on a P/E basis, but this is often justified by its exposure to the higher-growth premium spirits category and the defensive, cash-generative nature of its business; however, the current discount to its own history presents a potential value opportunity if the company's fundamentals stabilize.
PE
18.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 12x~80x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is not leverage or liquidity, given the strong balance sheet (D/E 0.68), but rather earnings stagnation. Revenue growth of just 2.71% YoY, if sustained, threatens the premium valuation (forward P/E 17.35x) the market assigns. Furthermore, the company's heavy reliance on its Whiskey segment (75% of last quarter's revenue) creates concentration risk, making overall results highly sensitive to the performance of a single, mature category. While free cash flow is robust at $730M TTM, a prolonged period of low growth could pressure margins and call into question the sustainability of shareholder returns.
Market & Competitive Risks: The stock faces significant valuation compression risk. It trades at a premium P/E to many consumer staples, yet its growth is lagging. With a beta of 0.42, it is less volatile than the market, but this did not prevent a 52.26% drawdown, showing it is not immune to severe sector-wide de-rating. Competitive risks are heightened as newer, craft spirits and ready-to-drink competitors chip away at market share, potentially capping the growth of the core Jack Daniel's brand. The recent shift in analyst ratings to 'Neutral' reflects this cautious, wait-and-see environment.
Worst-Case Scenario: The worst-case scenario involves a continuation of the current trends: revenue growth stagnates below 3%, competitive pressures intensify, and margins begin to contract from current elevated levels. This would trigger further analyst downgrades, validate the high short interest, and lead to a full derating of the stock towards its tangible asset value. A realistic downside target in this adverse scenario is a retest and break below the 52-week low of $22.61, representing a potential loss of approximately -23% from the current price of $29.49.
FAQ
The key risks are, in order of severity: 1) Growth Stagnation Risk: Revenue growth of only 2.71% YoY, if persistent, will lead to further valuation compression from its current forward P/E of 17.35x. 2) Competitive & Market Share Risk: Heavy reliance on the mature Jack Daniel's brand (75% of segment sales) makes the company vulnerable to shifting consumer preferences and competition from craft spirits and RTD entrants. 3) Sentiment & Technical Risk: High short interest (short ratio 11.39) and a severe 52.26% maximum drawdown indicate deep-seated negative sentiment that can fuel volatile swings. 4) Valuation Compression Risk: As a 'bond proxy' stock, it is sensitive to interest rate movements; sustained higher rates could pressure its premium multiple.
The 12-month forecast presents three scenarios with associated probabilities. The Base Case (60% probability) sees the stock trading between $29 and $32, as low-single-digit growth and strong cash flow result in range-bound action. The Bull Case (25% probability) projects a move to $34-$36, driven by accelerating revenue growth and a valuation re-rating. The Bear Case (15% probability) warns of a decline to $22-$25 if growth stalls and the stock retests its 52-week low. The base case is most likely, anchored by the assumption that the current tepid growth and fair valuation environment persists. The key variable determining the path is the next few quarters of revenue growth data.
BF-B is fairly valued. The stock trades at a forward P/E of 17.35x, which is a meaningful discount to its own historical multiples that exceeded 30x, suggesting it is undervalued relative to its past. However, compared to the broader consumer staples sector and given its current low-single-digit revenue growth rate, the multiple is at a premium, suggesting it is fairly valued or slightly overvalued for its growth profile. The market is effectively paying a fair price for a high-quality, stable, but slow-growing business. The valuation implies the market expects continued modest growth and does not anticipate a near-term reacceleration.
BF-B is a good buy only for a specific type of investor. For a value or defensive income investor comfortable with low growth, the company's strong balance sheet (D/E 0.68), robust free cash flow ($730M TTM), and discounted valuation relative to its own history (P/E 18.95x vs. historical highs >30x) are appealing. However, for growth-oriented investors, the anemic 2.71% revenue growth and premium multiple versus peers are significant drawbacks. The high short ratio of 11.39 also indicates substantial market skepticism. It is a good buy for those seeking quality at a reasonable price, but not for those seeking capital appreciation driven by top-line expansion.
BF-B is primarily suitable for a long-term investment horizon. Its low beta (0.42) and defensive characteristics align with a buy-and-hold strategy focused on capital preservation and steady dividend income (current yield 2.55%). The stock's recent volatility and technical bottoming process make it a challenging short-term trade, as it lacks a clear near-term catalyst for a major breakout. Given the need to see if the company can reignite its growth engine over several quarters, a minimum holding period of 2-3 years is suggested to allow the investment thesis—whether based on value realization or growth recovery—to play out.